A replication clock for Mycobacterium tuberculosis

被引:232
作者
Gill, Wendy P. [2 ]
Harik, Nada S. [3 ]
Whiddon, Molly R. [1 ,4 ]
Liao, Reiling P. [1 ]
Mittler, John E. [5 ]
Sherman, David R. [1 ,4 ]
机构
[1] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[2] Univ Washington, Med Ctr, Div Allerg & Infect Dis, Seattle, WA 98195 USA
[3] Univ Arkansas Med Sci, Div Pediat Infect Dis, Little Rock, AR 72202 USA
[4] Univ Washington, Dept Global Hlth, Interdisciplinary Program Pathobiol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
HOST-PARASITE EQUILIBRIUM; STATIONARY-PHASE; HYPOXIC RESPONSE; INFECTED MICE; GRANULOMAS; CHEMOTHERAPY; ZEBRAFISH; IMMUNITY; MURINE;
D O I
10.1038/nm.1915
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Few tools exist to assess replication of chronic pathogens during infection. This has been a considerable barrier to understanding latent tuberculosis, and efforts to develop new therapies generally assume that the bacteria are very slowly replicating or nonreplicating during latency(1-3). To monitor Mycobacterium tuberculosis replication within hosts, we exploit an unstable plasmid that is lost at a steady, quantifiable rate from dividing cells in the absence of antibiotic selection. By applying a mathematical model, we calculate bacterial growth and death rates during infection of mice. We show that during chronic infection, the cumulative bacterial burden enumerating total live, dead and removed organisms encountered by the mouse lung-is substantially higher than estimates from colony-forming units. Our data show that M. tuberculosis replicates throughout the course of chronic infection of mice and is restrained by the host immune system. This approach may also shed light on the replication dynamics of other chronic pathogens.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 32 条
  • [1] Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice
    Aly, S.
    Wagner, K.
    Keller, C.
    Malm, S.
    Malzan, A.
    Brandau, S.
    Bange, F-C
    Ehlers, S.
    [J]. JOURNAL OF PATHOLOGY, 2006, 210 (03) : 298 - 305
  • [2] [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
  • [3] A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon
    Bachrach, G
    Colston, MJ
    Bercovier, H
    Bar-Nir, D
    Anderson, C
    Papavinasasundaram, KG
    [J]. MICROBIOLOGY-UK, 2000, 146 : 297 - 303
  • [4] Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
    Cho, Sang Hyun
    Warit, Saradee
    Wan, Baojie
    Hwang, Chang Hwa
    Pauli, Guido F.
    Franzblau, Scott G.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1380 - 1385
  • [5] COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827
  • [6] Superinfecting mycobacteria home to established tuberculous granulomas
    Cosma, CL
    Humbert, O
    Ramakrishnan, L
    [J]. NATURE IMMUNOLOGY, 2004, 5 (08) : 828 - 835
  • [7] DAVISON AC, 1997, BOOTSTRAP METHODS TH, pCH2
  • [8] Tuberculosis
    Frieden, TR
    Sterling, TR
    Munsiff, SS
    Watt, CJ
    Dye, C
    [J]. LANCET, 2003, 362 (9387) : 887 - 899
  • [9] Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477
  • [10] EXPERIMENTAL STUDIES ON HOST-PARASITE EQUILIBRIUM IN TUBERCULOUS INFECTION IN RELATION TO VACCINATION AND CHEMOTHERAPY
    KANAI, K
    [J]. JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1966, 19 (04): : 181 - +